174 related articles for article (PubMed ID: 38015219)
1. Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial.
Winer RL; Lin J; Anderson ML; Tiro JA; Green BB; Gao H; Meenan RT; Hansen K; Sparks A; Buist DSM
JAMA; 2023 Nov; 330(20):1971-1981. PubMed ID: 38015219
[TBL] [Abstract][Full Text] [Related]
2. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial.
Winer RL; Lin J; Tiro JA; Miglioretti DL; Beatty T; Gao H; Kimbel K; Thayer C; Buist DSM
JAMA Netw Open; 2019 Nov; 2(11):e1914729. PubMed ID: 31693128
[TBL] [Abstract][Full Text] [Related]
3. Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening.
Meenan RT; Troja C; Buist DSM; Tiro JA; Lin J; Anderson ML; Gao H; Green BB; Winer RL
JAMA Netw Open; 2023 Mar; 6(3):e234052. PubMed ID: 36947040
[TBL] [Abstract][Full Text] [Related]
4. Design of a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake in a U.S. healthcare system: The STEP trial.
Winer RL; Lin J; Anderson ML; Tiro JA; Meenan RT; Hansen K; Gao H; Sparks A; Greene DN; Kilgore-Martin S; Green BB; Buist DSM
Contemp Clin Trials; 2022 Nov; 122():106960. PubMed ID: 36241145
[TBL] [Abstract][Full Text] [Related]
5. Effect of Patient Characteristics on Uptake of Screening Using a Mailed Human Papillomavirus Self-sampling Kit: A Secondary Analysis of a Randomized Clinical Trial.
Winer RL; Lin J; Tiro JA; Miglioretti DL; Beatty T; Gao H; Kimbel K; Thayer C; Buist DSM
JAMA Netw Open; 2022 Nov; 5(11):e2244343. PubMed ID: 36449291
[TBL] [Abstract][Full Text] [Related]
6. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.
Winer RL; Tiro JA; Miglioretti DL; Thayer C; Beatty T; Lin J; Gao H; Kimbel K; Buist DSM
Contemp Clin Trials; 2018 Jan; 64():77-87. PubMed ID: 29113956
[TBL] [Abstract][Full Text] [Related]
8. Impact of human papillomavirus (HPV) self-collection on subsequent cervical cancer screening completion among under-screened US women: MyBodyMyTest-3 protocol for a randomized controlled trial.
Spees LP; Des Marais AC; Wheeler SB; Hudgens MG; Doughty S; Brewer NT; Smith JS
Trials; 2019 Dec; 20(1):788. PubMed ID: 31881928
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
[TBL] [Abstract][Full Text] [Related]
10. Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial.
Montealegre JR; Anderson ML; Hilsenbeck SG; Chiao EY; Cantor SB; Parker SL; Daheri M; Bulsara S; Escobar B; Deshmukh AA; Jibaja-Weiss ML; Zare M; Scheurer ME
Trials; 2020 Oct; 21(1):872. PubMed ID: 33087164
[TBL] [Abstract][Full Text] [Related]
11. Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): a phase 3, open-label, randomised controlled trial.
Pretsch PK; Spees LP; Brewer NT; Hudgens MG; Sanusi B; Rohner E; Miller E; Jackson SL; Barclay L; Carter A; Wheeler SB; Smith JS
Lancet Public Health; 2023 Jun; 8(6):e411-e421. PubMed ID: 37182529
[TBL] [Abstract][Full Text] [Related]
12. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
[TBL] [Abstract][Full Text] [Related]
13. For due or overdue cervical cancer screening, direct or opt-in mailing of HPV self-sampling increased screening at 6 mo vs. education.
Batur P
Ann Intern Med; 2024 Apr; 177(4):JC46. PubMed ID: 38560899
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
[TBL] [Abstract][Full Text] [Related]
15. Does mailing unsolicited HPV self-sampling kits to women overdue for cervical cancer screening impact uptake of other preventive health services in a United States integrated delivery system?
Kariya H; Buist DSM; Anderson ML; Lin J; Gao H; Ko LK; Winer RL
Prev Med; 2022 Jan; 154():106896. PubMed ID: 34800474
[TBL] [Abstract][Full Text] [Related]
16. Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits.
Malone C; Tiro JA; Buist DS; Beatty T; Lin J; Kimbel K; Gao H; Thayer C; Miglioretti DL; Winer RL
J Med Screen; 2020 Sep; 27(3):146-156. PubMed ID: 31744374
[TBL] [Abstract][Full Text] [Related]
17. A Multilevel Primary Care Intervention to Improve Follow-Up of Overdue Abnormal Cancer Screening Test Results: A Cluster Randomized Clinical Trial.
Atlas SJ; Tosteson ANA; Wright A; Orav EJ; Burdick TE; Zhao W; Hort SJ; Wint AJ; Smith RE; Chang FY; Aman DG; Thillaiyapillai M; Diamond CJ; Zhou L; Haas JS
JAMA; 2023 Oct; 330(14):1348-1358. PubMed ID: 37815566
[TBL] [Abstract][Full Text] [Related]
18. Mailed HPV self-sampling for cervical cancer screening among underserved minority women: study protocol for a randomized controlled trial.
Kobetz E; Seay J; Amofah A; Pierre L; Bispo JB; Trevil D; Gonzalez M; Poitevien M; Koru-Sengul T; Carrasquillo O
Trials; 2017 Jan; 18(1):19. PubMed ID: 28086983
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of mailed HPV self-sampling for cervical cancer screening among ethnic minority women in South Florida.
Kobetz E; Seay J; Koru-Sengul T; Bispo JB; Trevil D; Gonzalez M; Brickman A; Carrasquillo O
Cancer Causes Control; 2018 Sep; 29(9):793-801. PubMed ID: 29995217
[TBL] [Abstract][Full Text] [Related]
20. Understanding Patients' Perspectives and Information Needs Following a Positive Home Human Papillomavirus Self-Sampling Kit Result.
Tiro JA; Betts AC; Kimbel K; Buist DSM; Mao C; Gao H; Shulman L; Malone C; Beatty T; Lin J; Thayer C; Miglioretti DL; Winer RL
J Womens Health (Larchmt); 2019 Mar; 28(3):384-392. PubMed ID: 30481121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
